Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Abciximab reduces mortality in diabetics following percutaneous coronary intervention.

Abciximab reduces mortality in diabetics following percutaneous coronary intervention. J Am Coll Cardiol. 2000 Mar 15; 35(4):922-8.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.